Skip to content
  • Argentina
  • Brazil
  • Canada
  • Chile
  • Colombia
  • Europe
  • France
  • Germany
  • India
  • Italy
  • Japan
  • Korea
  • Mexico
  • Perú
  • Russia
  • Spain
  • Taiwan
  • The Middle East
  • Turkey
  • United Kingdom
  • United States
  • Vietnam
  • Country/Region
    • Clinic Portal
      • +0034963905310
    • Request Information
    • +34 96 390 53 10
    InternationalInternational
    • Country/Region
    • We guide you
      • Fertility
        • What to do if…
      • Prevent Inherited Diseases
        • Carrier Genetic Test
      • Worry-free Pregnancy
        • NACE
        • Prenatal Diagnostics
        • Newborn Health
    • Reproductive Health
      • Specialists
        • ALICE
        • EMMA
        • ERA
        • EndomeTRIO
        • EMBRACE
        • CGT
        • NACE
        • Zenit
        • PGT-A
        • PGT-M
        • POC
        • SAT
        • Newborn Screening
      • Patients
        • ALICE
        • EMMA
        • ERA
        • EndomeTRIO
        • EMBRACE
        • CGT
        • NACE
        • Zenit
        • PGT-A
        • PGT-M
        • SAT
        • POC
    • Diagnostics
    • About us
      • Igenomix Research
      • About Igenomix
    • Academy
    • Blog
        Genomics Precision Diagnostic > Metabolic Precision Panel > Leigh Syndrome and Mitochondrial Encephalopathy Precision Panel

        Leigh Syndrome and Mitochondrial Encephalopathy Precision Panel

        Congenital Disorders of Glycosylation (CDG) are a group of rapidly expanding metabolic disorders that arise due to abnormal protein or lipid glycosylation. There are difficulties trying to diagnose them because they broadly affect many organs and functions, demonstrating a clinical heterogeneity. 
        Overview
        Indication
        Clinical Utility
        Genes & Diseases
        Methodology
        References

        Overview

        • Leigh syndrome (subacute necrotizing encephalomyelopathy) is a severe neurological disorder that generally presents in infancy or early childhood, although it can appear during late childhood and even adulthood. It is characterized by developmental delay or psychomotor regression, ataxia, dystonia, external ophthalmoplegia, seizures, vomiting and weakness. The phenotype of Leigh syndrome is caused by alterations of mitochondrial metabolism from a variety of mechanisms including pyruvate dehydrogenase complex and respiratory chain dysfunction due to either nuclear or mitochondrial DNA mutations. This, in turn, results in brain lesions and damage of myelin sheaths coating the nerves. Leigh syndrome can have different inheritance patterns but it is most commonly inherited in an autosomal recessive pattern.  

        • The Igenomix Leigh Syndrome and Mitochondrial Encephalopathy Precision Panel can be used to make an accurate and directed diagnosis ultimately leading to a better management and prognosis of the disease. It provides a comprehensive analysis of the genes involved in this disease using next-generation sequencing (NGS) to fully understand the spectrum of relevant genes involved.  

           

        Indication

        • The Igenomix Leigh Syndrome and Mitochondrial Encephalopathy Precision Panel is indicated for those patients with a clinical suspicion or diagnosis with or without the following manifestations during the newborn period: 
          • Psychomotor regression 
          • Ataxia 
          • Dystonia 
          • Hypotonia 
          • External Ophthalmoplegia 
          • Lactic acidosis 
          • Vomiting 
          • Weakness 
          • Delayed growth development 

        Clinical Utility

        The clinical utility of this panel is: 

        • The genetic and molecular confirmation for an accurate clinical diagnosis of a symptomatic patient.  
        • Early initiation of multidisciplinary treatment including supplements, vitamins, pyruvate, dichloroacetate and a ketogenic diet. Consider immunomodulatory therapies if necessary. 
        • Risk assessment and genetic counselling of asymptomatic family members according to the mode of inheritance. 
        • Improvement of delineation of genotype-phenotype correlation. 

        Genes & Diseases

        Methodology

        References

        See scientific referrals

        Finsterer, J. (2008). Leigh and Leigh-Like Syndrome in Children and Adults. Pediatric Neurology, 39(4), 223-235. doi: 10.1016/j.pediatrneurol.2008.07.013 

        Rahman, S., Blok, R., Dahl, H., Danks, D., Kirby, D., & Chow, C. et al. (1996). Leigh syndrome: Clinical features and biochemical and DNA abnormalities. Annals Of Neurology, 39(3), 343-351. doi: 10.1002/ana.410390311 

        Lee, H., Tsai, C., Chi, C., Lee, H., & Chen, C. (2009). Leigh Syndrome: Clinical and Neuroimaging Follow-Up. Pediatric Neurology, 40(2), 88-93. doi: 10.1016/j.pediatrneurol.2008.09.020 

        Lake, N., Compton, A., Rahman, S., & Thorburn, D. (2015). Leigh syndrome: One disorder, more than 75 monogenic causes. Annals Of Neurology, 79(2), 190-203. doi: 10.1002/ana.24551 

        Baertling, F., Rodenburg, R. J., Schaper, J., Smeitink, J. A., Koopman, W. J., Mayatepek, E., Morava, E., & Distelmaier, F. (2014). A guide to diagnosis and treatment of Leigh syndrome. Journal of neurology, neurosurgery, and psychiatry, 85(3), 257–265. https://doi.org/10.1136/jnnp-2012-304426 

        Lake, N. J., Bird, M. J., Isohanni, P., & Paetau, A. (2015). Leigh syndrome: neuropathology and pathogenesis. Journal of neuropathology and experimental neurology, 74(6), 482–492. https://doi.org/10.1097/NEN.0000000000000195 

        Chen, L., Cui, Y., Jiang, D., Ma, C. Y., Tse, H. F., Hwu, W. L., & Lian, Q. (2018). Management of Leigh syndrome: Current status and new insights. Clinical genetics, 93(6), 1131–1140. https://doi.org/10.1111/cge.13139 

        descargar

        Detail description

        Download

        Request Information


        WE GUIDE YOU

        Fertility
        Inherited diseases prevention
        Healthy pregnancy

        To see the accreditation certificate, associated technical annex and list of accredited tests, click on this link.

        OUR SERVICES

        Genetic solutions
        For patients
        How to send a sample?
        User manual

        ABOUT US

        About Igenomix
        Contact
        Quality
        Complaints
        Work with us

        FOLLOW IGENOMIX

          + 96 390 53 10
          Write us
        • Argentina
        • Brazil
        • Canada
        • Chile
        • Colombia
        • Europe
        • France
        • Germany
        • India
        • Italy
        • Japan
        • Korea
        • Mexico
        • Perú
        • Russia
        • Spain
        • Taiwan
        • The Middle East
        • Turkey
        • United Kingdom
        • United States
        • Vietnam
        Country/Region

        [2021] © Igenomix Privacy policy Quality policy Legal note Cookies policyNews and Press

        Request Information


        • We guide you
          • Fertility
            • What to do if…
          • Prevent Inherited Diseases
            • Carrier Genetic Test
          • Worry-free Pregnancy
            • NACE
            • Prenatal Diagnostics
            • Newborn Health
        • Reproductive Health
          • Specialists
            • ALICE
            • EMMA
            • ERA
            • EndomeTRIO
            • EMBRACE
            • CGT
            • NACE
            • Zenit
            • PGT-A
            • PGT-M
            • POC
            • SAT
            • Newborn Screening
          • Patients
            • ALICE
            • EMMA
            • ERA
            • EndomeTRIO
            • EMBRACE
            • CGT
            • NACE
            • Zenit
            • PGT-A
            • PGT-M
            • SAT
            • POC
        • Diagnostics
        • About us
          • Igenomix Research
          • About Igenomix
        • Academy
        • Blog
        • Country/Region
        • +34 96 390 53 10
        • Clinic Portal
        • Request Information

        We are using cookies to give you the best experience on our website.

        You can find out more about which cookies we are using or switch them off in settings.

        International
        Powered by  GDPR Cookie Compliance
        Privacy Overview

        This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

        Strictly Necessary Cookies

        Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

        If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

        3rd Party Cookies

        This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

        Keeping this cookie enabled helps us to improve our website.

        Please enable Strictly Necessary Cookies first so that we can save your preferences!

        Cookie Policy

        More information about our Cookie Policy